Cite

HARVARD Citation

    Errani, C. et al. (2018). Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage. Journal of bone and joint surgery. p. . [Online]. 
  
Back to record